Mibefradil--a new calcium-channel blocker.
D000787:Angina Pectoris / Q000188:drug therapy; D001562:Benzimidazoles / Q000009:adverse effects / Q000493:pharmacokinetics*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000493:pharmacokinetics*; D002986:Clinical Trials as Topic; D000075202:Contraindications; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D020748:Mibefradil; D013764:Tetrahydronaphthalenes / Q000009:adverse effects / Q000493:pharmacokinetics*
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil